Close

Articles

Antibiotic powders : Maximum safety and efficiency during filling

Pharmaceutical powders form the basis for numerous antibiotics that are essential for comprehensive medical care. However, margins are low and production conditions are complex. What kind of equipment and support do drug manufacturers and contract manufacturers need to make...

Ayushman Bharat Digital Mission: The Benefit and Future of Digitisation in the Medical Sciences

The current Ayushman Bharat Digital Mission by the PM to allow greater IT-penetration of healthcare is welcome news. What makes it doubly so, is the focus on digital health such as app-based solutions. This is because leveraging digital technology...

A Collaborative Effort Paves the Way for a New Approach to Small Batch Manufacturing

In today’s pharmaceutical industry there is a sharp focus on the needs and requirements of the patient. More and more drugs are being developed for specific patient groups.Orphan drugs, for example,may require small batch sizes ranging anywhere from 500...

Achieving Sustainable Improvements

Pharmaceutical service provider is focused on sustainability The history of Vetter started with a simple pharmacy. This late Gothic, half-timbered house in Ravensburg's city center is a reminder of these first entrepreneurial steps taken by the founder, Senator h.c. Helmut...

Why real-world data is helping us overcome the shortcomings of traditional clinical trials

Karen Ooms at Quanticate explains why clinical trial data alone is not enough to truly understand a drug’s effectiveness and argues that real-world data (RWD) is the key to filling the gap. Randomized clinical trials have long been a...

Injectable Drug Delivery Trends

How Global Trends Are Driving Patient-Centricity in Parenteral Products. Parenteral products represent a major growth engine in today’s surging global biopharma market. Their share of the global market figures to grow from 53% in 2020 ($606bn) to 57% in 2027...

Vaccine Temperatures: Keeping it cool for COVID-19

With more vaccines being approved worldwide, maintaining the shipments’ integrity throughout the delivery process is the most challenging hurdle for many logistics providers. Since the first COVID-19 vaccine was approved in December last year – Pfizer-BioNTech’s mRNA vaccine – there...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read